VIA EDGAR
November 8, 2010
Mr. James Lopez
Branch Chief
Division of Corporation Finance
United States Securities and Exchange Commission
100 F. Street, N.E.
Washington, D.C. 20549
| RE: | Biomet, Inc. |
Bioelectron, Inc.
Biomet 3i, LLC
Biomet Biologics, LLC
Biomet Europe Ltd.
Biomet Fair Lawn, LLC
Biomet International Ltd.
Biomet Leasing, Inc.
Biomet Manufacturing Corporation
Biomet Microfixation, LLC
Biomet Orthopedics, LLC
Biomet Sports Medicine, LLC
Cross Medical Products, LLC
EBI Holdings, LLC
EBI, LLC
EBI Medical Systems, LLC
Electro-Biology, LLC
Biomet Florida Services, LLC
Implant Innovations Holdings, LLC
Interpore Cross International, LLC
Interpore Spine Ltd.
Kirschner Medical Corporation (collectively, the “Registrants”)
Post-Effective Amendment No. 5 to Form S-1
Filed September 15, 2010
File No. 333-150655
Dear Mr. Lopez,
Biomet, Inc. (referred to herein as the “Company”, “we”, or “our”) hereby makes application for itself and on behalf each of the other Registrants (each a direct or indirect wholly-owned subsidiary of the Company), pursuant to paragraph (a) of Rule 477 under the Securities Act of 1933, as amended, to withdraw Post-Effective Amendment No. 5 to Form S-1 (File No. 333-150655) (the “Post-Effective
| Mailing Address: | Shipping Address: | |||||||
P.O. Box 587 | 56 East Bell Drive | |||||||
Warsaw, IN 46581-0587 | Warsaw, IN 46582 | |||||||
Toll Free: 800.348.9500 | ||||||||
Office: 574.267.6639 | ||||||||
Main Fax: 574.267.8137 | ||||||||
www.biomet.com |
Amendment”), filed by the Registrants with the Securities and Exchange Commission (the “Commission”) on September 15, 2010.
The Company caused its subsidiaries Biomet Holdings Ltd. and Biomet Travel, Inc. to be dissolved on August 30, 2010 and June 16, 2010, respectively, and had inadvertently filed the Post-Effective Amendment under such Registrants’ EDGAR filing codes.
The Post Effective Amendment has not been declared effective and the Company confirms that no securities have been or will be sold under the Post-Effective Amendment.
It is our understanding that this application for withdrawal of the amendment will be deemed granted as of the date that it is filed with the Securities and Exchange Commission (the “Commission”) unless, within fifteen days after such date, the Company receives notice from the Commission that this application will not be granted.
If you have any questions regarding this application, please contact me at (574) 371-3026.
Sincerely,
/s/ Jody S. Gale
Jody S. Gale
Vice President and Associate General Counsel